Radionuclide intake risks in the clinical administration of


Journal

Journal of radiological protection : official journal of the Society for Radiological Protection
ISSN: 1361-6498
Titre abrégé: J Radiol Prot
Pays: England
ID NLM: 8809257

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 5 2 2019
medline: 17 7 2020
entrez: 5 2 2019
Statut: ppublish

Résumé

An intake monitoring program covering more than half a year of clinical administration of Radium-223-dichloride for the palliative treatment of castration-resistant prostate cancer was carried out in the nuclear medicine department of the university hospital Bonn. Radioactivity in a total of 87 samples of gloves, air filters, faecal bioassays and face masks was measured and evaluated to assess the need for radiation protection measures for the medical staff. The main aim was to quantify or obtain an upper limit for the intake factor. An intake factor of 10

Identifiants

pubmed: 30716726
doi: 10.1088/1361-6498/ab044d
doi:

Substances chimiques

Antineoplastic Agents 0
Radioisotopes 0
radium Ra 223 dichloride RJ00KV3VTG
Radium W90AYD6R3Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

387-398

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH